[HTML][HTML] Cross-linking ligation and sequencing of hybrids (qCLASH) reveals an unpredicted miRNA targetome in melanoma cells
I Kozar, D Philippidou, C Margue, LA Gay, R Renne… - Cancers, 2021 - mdpi.com
Simple Summary miRNAs are omnipresent short non-coding RNA molecules, which post-
transcriptionally fine-tune the expression of most protein-coding genes in health and …
transcriptionally fine-tune the expression of most protein-coding genes in health and …
[HTML][HTML] Concomitant antihyperalgesic and antitumor effects of gabapentin in a murine cancer pain model
BE Brito, MA García, YM De Gouveia… - International journal of …, 2021 - mdpi.com
Cancer pain may be the consequence of physical nerve compression by a growing tumor.
We employed a murine model to study whether gabapentin was able to regulate tumor …
We employed a murine model to study whether gabapentin was able to regulate tumor …
[HTML][HTML] BRAF/EZH2 signaling represses miR-129-5p inhibition of SOX4 thereby modulating BRAFi resistance in melanoma
K Gebhardt, B Edemir, E Gross, L Nemetschke… - Cancers, 2021 - mdpi.com
Simple Summary Approximately 60% of all melanomas are associated with a constitutive
activating BRAF mutation. Inhibition of BRAF downstream signaling by targeted therapies …
activating BRAF mutation. Inhibition of BRAF downstream signaling by targeted therapies …
miRNAs in melanoma: tumor suppressors and oncogenes with prognostic potential
M Wozniak, A Mielczarek, M Czyz - Current medicinal …, 2016 - ingentaconnect.com
MicroRNAs (miRNAs), which are small non-coding RNA molecules that post-
transcriptionally regulate the expression of target genes, control the vast majority of cellular …
transcriptionally regulate the expression of target genes, control the vast majority of cellular …
[HTML][HTML] miR-410-3p is induced by vemurafenib via ER stress and contributes to resistance to BRAF inhibitor in melanoma
Despite significant development of melanoma therapies, death rates remain high.
MicroRNAs, controlling posttranscriptionally gene expression, play role in development of …
MicroRNAs, controlling posttranscriptionally gene expression, play role in development of …
[HTML][HTML] Genetic layout of melanoma lesions is associated with BRAF/MEK-targeted therapy resistance and transcriptional profiles
E Vergani, A Busico, M Dugo, A Devecchi… - Journal of Investigative …, 2022 - Elsevier
The genetic landscape of melanoma resistance to targeted therapy with small molecules
inhibiting BRAF and MEK kinases is still largely undefined. In this study, we portrayed in …
inhibiting BRAF and MEK kinases is still largely undefined. In this study, we portrayed in …
[HTML][HTML] Current understanding of epigenetics role in melanoma treatment and resistance
M Karami Fath, A Azargoonjahromi, A Soofi… - Cancer cell …, 2022 - Springer
Melanoma is the most aggressive form of skin cancer resulting from genetic mutations in
melanocytes. Several factors have been considered to be involved in melanoma …
melanocytes. Several factors have been considered to be involved in melanoma …
[HTML][HTML] Identification of microRNA–mRNA networks in melanoma and their association with PD-1 checkpoint blockade outcomes
Simple Summary We conducted a network analysis of microRNA–mRNA associations in
melanoma tissue and cell lines to identify the microRNAs central to melanoma biology and …
melanoma tissue and cell lines to identify the microRNAs central to melanoma biology and …
Impact of BRAF kinase inhibitors on the miRNomes and transcriptomes of melanoma cells
I Kozar, G Cesi, C Margue, D Philippidou… - Biochimica et Biophysica …, 2017 - Elsevier
Background Melanoma is an aggressive skin cancer with increasing incidence worldwide.
The development of BRAF kinase inhibitors as targeted treatments for patients with BRAF …
The development of BRAF kinase inhibitors as targeted treatments for patients with BRAF …
Exploring the role of epigenetic alterations and non-coding RNAs in melanoma pathogenesis and therapeutic strategies
M Rubatto, S Borriello, N Sciamarrelli, V Pala… - Melanoma …, 2023 - journals.lww.com
Melanoma is a rare but highly lethal type of skin cancer whose incidence is increasing
globally. Melanoma is characterized by high resistance to therapy and relapse. Despite …
globally. Melanoma is characterized by high resistance to therapy and relapse. Despite …